Monkeypox Vaccination Encouraged for Countries Offering Vaccination

WHOEurope Encourages Countries to Consider Mpox Vaccination

The World Health Organization (WHO) Europe has encouraged countries that are offering vaccination against monkeypox to consider making access to the vaccine more widely available. The WHO has stated that the vaccine is safe and effective and that it can help to protect individuals from becoming infected with the virus.

Mpox: A Rare Viral Disease

Monkeypox is a rare viral disease that causes symptoms of an acute viral infection, including fever, headache, muscle aches, and a rash. The virus is spread through close contact with an infected person or animal, or through contact with contaminated objects. Monkeypox can be serious, but most people recover within a few weeks.

Mpox Vaccination Strategy in Spain

Spanish health authorities approved a new monkeypox vaccination strategy on Monday, allowing more people to get vaccinated against the virus. The new strategy includes making the vaccine available to healthcare workers, people who have been in close contact with an infected person, and people who are at high risk of exposure to the virus.

There is One Vaccine Authorized for Use Against Monkeypox Disease in the EU

There is one vaccine authorized for use against monkeypox disease in the European Union (EU). The vaccine is called Jynneos and it is a live attenuated vaccine, which means that it contains a weakened form of the monkeypox virus. The vaccine is given in two doses, and it is approximately 85% effective in preventing monkeypox disease.